Aptose Biosciences (APTO) PT Lowered to $18 at RBC Capital
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Price: $1.71 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
RBC Capital analyst Gregory Renza lowered the price target on Aptose Biosciences (NASDAQ: APTO) to $18.00 (from $23.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities
- Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
